Evidence map›Paper›PMID 41593361›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Multidisciplinary team interpretation performance for indeterminate bone uptake on PSMA PET during prostate cancer staging: Comparison with PROMISE criteria.

Dimitrios Priftakis, Fadilah Aziz, Noora Bin Essa, Reena Davda, Maria Lyasheva, Sudeshna Maitra, Francesco Fraioli, Simon Wan, Jamshed Bomanji, Asim Afaq

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dimitrios PriftakisInstitute of Nuclear Medicine, University College London Hospital, 235 Euston Road, London, NW1 2BU, UK. dimitris.priftakis@nhs.net.
Fadilah AzizInstitute of Nuclear Medicine, University College London Hospital, 235 Euston Road, London, NW1 2BU, UK.
Noora Bin EssaInstitute of Nuclear Medicine, University College London Hospital, 235 Euston Road, London, NW1 2BU, UK.
Reena DavdaDepartment of Uro-oncology, University College London Hospital, London, UK.
Maria LyashevaDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Sudeshna MaitraInstitute of Nuclear Medicine, University College London Hospital, 235 Euston Road, London, NW1 2BU, UK.
Francesco FraioliInstitute of Nuclear Medicine, University College London Hospital, 235 Euston Road, London, NW1 2BU, UK.
Simon WanInstitute of Nuclear Medicine, University College London Hospital, 235 Euston Road, London, NW1 2BU, UK.
Jamshed BomanjiInstitute of Nuclear Medicine, University College London Hospital, 235 Euston Road, London, NW1 2BU, UK.
Asim AfaqInstitute of Nuclear Medicine, University College London Hospital, 235 Euston Road, London, NW1 2BU, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo compare the performance of a multidisciplinary team (MDT) with the proposed standardized PROMISE classification system for indeterminate bone uptake on staging PSMA PET.

methods744 staging PSMA PET/CT scans (140

resultsThe overall incidence of indeterminate bone uptake in staging PSMA PET scans was 16.9%, reaching 40% for

conclusionPROMISE may interpret indeterminate bone PSMA uptake with high accuracy. Therefore, PET reporters are recommended to use the PROMISE algorithm, while being mindful of common pitfalls related to the Gleason score, tracer used and anatomical localisation of indeterminate bone findings. Additional discussion in an MDT meeting is recommended with a view to resolve all equivocal findings.

Indexed as

Bone NeoplasmsOligopeptidesPatient Care TeamPositron Emission Tomography Computed TomographyProstatic NeoplasmsAgedAged, 80 and overBiological TransportGallium IsotopesGallium RadioisotopesHumansMaleMiddle AgedNeoplasm StagingNiacinamideRetrospective StudiesGallium IsotopesGallium RadioisotopesNiacinamideOligopeptidesPSMA-100718F-PSMA-100768Ga-PSMA-11Bone metastasesProstate cancerPSMA PET

Identifiers

PMID41593361

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.